HTA18 Impact of The Use of Cost-Effectiveness Analysis (CEA) on Patient Access to Medicines: A Comparison of CEA vs Non-CEA Markets
Dec 1, 2022, 00:00 AM
10.1016/j.jval.2022.09.1478
https://www.valueinhealthjournal.com/article/S1098-3015(22)03683-X/fulltext
Section Title :
Section Order :
11018
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)03683-X&doi=10.1016/j.jval.2022.09.1478